satyamspot on 21st Jul

As stated in a recently published information by Credence Research, Inc. “Global Irritable Bowel Syndrome with Diarrhea (IBS-D) industry – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016-2022,” the irritable bowel syndrome with diarrhea (IBS-D) drugs industry was valued at USD 289.3 Mn in 2015, and is expected to reach...